Trial Data Reveals the Limitations of Steroids in Giant Cell Arteritis Therapy
Study Finds Tocilizumab Could Be Treatment Option for Takayasu Arteritis
Treatment Tips for Pulmonary Arterial Hypertension & ILD
Alendronate May Provide Cardiovascular Benefits; Plus FDA Approves Subcutaneous Tocilizumab
Exciting Advances in Giant Cell Arteritis Diagnosis & Treatment
The FDA Approved Several New Rheumatology Drugs in 2017
Tocilizumab Monotherapy May Sustain Low Disease Activity in RA Patients
Tocilizumab a “First Choice” for PHID Syndrome
